In light of the above information, we recommend that HBV infected individuals take Gene-Eden-VIR or Novirin. - Mike Evans, polyDNA
Rochester, NY (PRWEB) June 22, 2014
The hepatitis B virus (HBV) is strongly linked to pancreatic cancer. As Dr. Majumder and his team wrote in a recent meta-analysis “BsAg positivity (an HBV protein) is associated with an increased risk of pancreatic cancer.” (1) Dr. Majumder’s findings are important since pancreatic cancer is projected to become the second leading cause of cancer deaths by 2030. Lynn Matrisian, PhD said that “The projections for deaths from pancreatic and liver cancers are startling.” (See Oncology Nurse Advisor, from May 30, 2014) (2) According to Dr. Matrisian, one of the major factors in pancreatic cancer incidence and death is “prevalence of smoking and viral infections.” (2)
polyDNA recommends that people with a hepatitis B (HBV) infection take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the CMV, HBV, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (hepatitis B and other viruses)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Both products can be ordered online on the Gene-Eden-VIR and Novirin websites.
Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.
One of those studies said that “catechins, found in green tea, are effective against viruses such as (the) … Hepatitis Virus B (HVB), and other viruses.” (3) The formula of Gene-Eden-VIR and Novirin contain green tea extract.
Dr. Fiorino and colleagues agree with Dr. Majumder. They wrote that “Hepatitis B (HBV) and hepatitis C virus (HCV) possess well-known oncogenic properties (cancer development) and … have been also detected in different extra-hepatic tissues, including the pancreas… (and) … epidemiological studies and meta-analyses have recently suggested that HBV/HCV may be also risk factors for pancreatic cancer.” (See JOP: The Journal of the Pancreas, from March 10, 2014) (4)
Pancreatic cancer is projected to surpass breast, prostate, and colorectal cancers to become the second leading causes of cancer death according to the pancreatic Cancer Action Network in Manhattan Beach, California. (2)
“Hepatitis B is caused by infection with the Hepatitis B virus (HBV). The incubation period from the time of exposure to onset of symptoms is 6 weeks to 6 months. HBV is found in highest concentrations in blood and in lower concentrations in other body fluids (e.g., semen, vaginal secretions, and wound exudates).” (See the CDC, from May 16, 2012) (5).
“In light of the above information, we recommend that HBV infected individuals take Gene-Eden-VIR or Novirin.” - Mike Evans, polyDNA
All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Association Between HBsAg Positivity and Pancreatic Cancer: a Meta-Analysis. Published on May 2, 2014.
(2) Pancreatic cancer to become second-leading cause of cancer death by 2030. Published on May 30, 2014.
(3) Gene-Eden-VIR is Antiviral: Results of a Post marketing clinical study. Published in September 2013.
(4) Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection?Published on March 10, 2014.
(5) CDC - Hepatitis B Information for Health Professionals. Last updated on May 16, 2012. http://www.cdc.gov/hepatitis/hbv/